Nanjing Hicin Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -1.75% vs 16.34% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -76.26% vs -7.33% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "163.00",
          "val2": "165.90",
          "chgp": "-1.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.10",
          "val2": "31.80",
          "chgp": "-90.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "1.80",
          "chgp": "-22.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.30",
          "val2": "13.90",
          "chgp": "-76.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.90%",
          "val2": "105.40%",
          "chgp": "-8.65%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.50% vs -1.86% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.74% vs 13.08% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "498.30",
          "val2": "511.10",
          "chgp": "-2.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "96.00",
          "val2": "97.00",
          "chgp": "-1.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.20",
          "val2": "8.30",
          "chgp": "10.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.20",
          "val2": "36.30",
          "chgp": "10.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "99.90%",
          "val2": "85.00%",
          "chgp": "1.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

163.00

165.90

-1.75%

Operating Profit (PBDIT) excl Other Income

3.10

31.80

-90.25%

Interest

1.40

1.80

-22.22%

Exceptional Items

0.00

0.00

Consolidate Net Profit

3.30

13.90

-76.26%

Operating Profit Margin (Excl OI)

18.90%

105.40%

-8.65%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -1.75% vs 16.34% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -76.26% vs -7.33% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

498.30

511.10

-2.50%

Operating Profit (PBDIT) excl Other Income

96.00

97.00

-1.03%

Interest

9.20

8.30

10.84%

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

40.20

36.30

10.74%

Operating Profit Margin (Excl OI)

99.90%

85.00%

1.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -2.50% vs -1.86% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 10.74% vs 13.08% in Dec 2023

All Annual Results